Inici › Leucèmia mieloide aguda › Geòrgia › Augusta
Assaigs clínics de Leucèmia mieloide aguda a Augusta, GA
10 estudis de Leucèmia mieloide aguda busquen participants en centres de Augusta i voltants (en un radi d'uns 30 milles). Obre un estudi per veure qui hi pot participar i com contactar amb l'equip.
Text oficial de l'estudi (anglès)
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
ReclutantFase 2
- Augusta University Medical Center, Augusta
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
ReclutantFase 2
- Augusta University Medical Center, Augusta
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
ReclutantFase 2
- Augusta University Medical Center, Augusta
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
ReclutantFase 2
- Augusta University Medical Center, Augusta
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
ReclutantFase 3
- Augusta University Medical Center, Augusta
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
ReclutantFase 1
- Georgia Cancer Center at Augusta University, Augusta
L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML
ReclutantFase 2/3
- Augusta University - Georgia Cancer Center, Augusta
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
ReclutantEstudi observacional
- Georgia Cancer Center at Augusta University Health, Augusta
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
ReclutantFase 1
- Georgia Cancer Center at Augusta University, Augusta
Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
ReclutantFase 2
- Georgia Cancer Center at Augusta University, Augusta
Assaigs de Leucèmia mieloide aguda en altres ciutats
- Houston, TX85 estudis
- New York City, NY51 estudis
- Boston, MA44 estudis
- Baldwin Park, CA40 estudis
- Seattle, WA40 estudis
- Columbus, OH35 estudis
- Philadelphia, PA34 estudis
- Durham, NC33 estudis
- Atlanta, GA30 estudis
- Tampa, FL29 estudis
- Chicago, IL26 estudis
- Portland, OR25 estudis
Altres estudis a Augusta
- Càncer d'ovari8 estudis
- Càncer d'endometri7 estudis
- Càncer (tots els tipus)7 estudis
- Anèmia falciforme5 estudis
- Càncer de mama5 estudis
- Miastènia gravis4 estudis
- Càncers de la sang4 estudis
- Limfoma de Burkitt4 estudis
- Limfoma difús de cèl·lules B grans4 estudis
- Leucèmia mieloide crònica4 estudis
- Limfoma no Hodgkin4 estudis
- Càncer de coll d'úter4 estudis
De ClinicalTrials.gov, dades recuperades el 5 d’oct. 2026. Cada estudi estableix els seus propis criteris d'elegibilitat; l'equip de l'estudi decideix qui hi pot participar.